Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Bioscience and Biotechnology

ISSN Print: 2156-8456
ISSN Online: 2156-8502
www.scirp.org/journal/abb
E-mail: abb@scirp.org

Google-based Impact Factor: 1.26
Citations

Journals Menu

"Strategies to stabilize compact folding and minimize aggregation of antibody-based fragments"
written by Diana Gil, Adam G. Schrum,
published by Advances in Bioscience and Biotechnology, Vol.4 No.4A, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Novel technologies for applying immune checkpoint blockers
	International Review of Cell and Molecular Biology, 2024

[2]	Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
	Journal of Controlled …, 2024

[3]	Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties
	International Journal of …, 2024

[4]	NMDA receptor autoantibodies primarily impair the extrasynaptic compartment
	Brain, 2024

[5]	Immunoglobulin constant regions provide stabilization to the paratope and enforce epitope specificity.
	Journal of Biological Chemistry, 2024

[6]	Exosome-mimetic vesicles derived from fibroblasts carrying matrine for wound healing
	Burns & …, 2024

[7]	Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic
	Frontiers in …, 2024

[8]	Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors
	PNAS …, 2024

[9]	Higher order structure characterization of two interdomain disulfide bond variants of a bispecific monoclonal antibody
	Journal of Pharmaceutical Sciences, 2024

[10]	B7-H3-Targeting Chimeric Antigen Receptors Epstein Barr Virus Specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3 Positive Solid …
	Cancer Research …, 2024

[11]	Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry
	Mabs, 2024

[12]	Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement
	Immunology, 2024

[13]	Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing
	Applied Sciences, 2023

[14]	Molecular impact of anti-NMDA receptor autoantibodies
	2023

[15]	Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice
	International Journal of …, 2023

[16]	Mutated Flt3Lg provides reduced Flt3 recycling compared to wild-type Flt3Lg and retains the specificity of Flt3Lg-based CAR T-cell targeting in AML models
	International Journal of …, 2023

[17]	“Stapling” scFv for multispecific biotherapeutics of superior properties
	Mabs, 2023

[18]	Emerging applications of nanobodies in cancer therapy
	International review of …, 2022

[19]	Charakterisierung bi-und trispezifischer antiCD40 Antikörper-Fusionsproteine
	2022

[20]	Herstellung und Charakterisierung von anti-CD40-und anti-41BB-Fusionsproteinen mit PDL1-abhängiger agonistischer Aktivität
	2022

[21]	Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody …
	Frontiers in …, 2022

[22]	A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments
	Nature …, 2022

[23]	Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis
	Molecular …, 2022

[24]	Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
	Kok, D Panella, AM Georgoudaki… - Journal of Hematology & …, 2022

[25]	Nanobody-based CAR-T cells for cancer immunotherapy
	Biomarker …, 2022

[26]	Improvement in the binding specificity of anti-isomiroestrol antibodies by expression as fragments under oxidizing conditions inside the SHuffle T7 E. coli cytoplasm
	Bioscience …, 2022

[27]	Expression of functional eGFP-fused antigen-binding fragment of ranibizumab in Pichia pastoris
	BioImpacts …, 2022

[28]	NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies
	bioRxiv, 2022

[29]	Emerging applications of nanobodies in cancer therapy.
	International review of …, 2022

[30]	Development of antibody therapeutic approaches for poultry diseases using avian influenza as a disease model
	2022

[31]	Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains
	Frontiers in Molecular …, 2022

[32]	CAR T-cell therapy σε υγρούς και στερεούς όγκους
	2022

[33]	Julia Hambach1, 2, Anna Marei Mann1, Peter Bannas2 and Friedrich Koch-Nolte1
	2022

[34]	A study of the practicality of cell-free protein synthesis for the commercial manufacture of monoclonal antibodies
	2022

[35]	Natural Killer Cell Immune Engagers to Induce Optimal Anti-Tumor Activity
	2021

[36]	Productıon of Recombınant Antıbody Fragments in Bacterıa and Theır Development Towards Medıcal Dıagnosıs
	2021

[37]	Development of BCMA-specific engineered T cells targeting multiple myeloma
	2021

[38]	Natural Receptor-and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
	Cells, 2021

[39]	CAR-NK Cells in the Treatment of Solid Tumors
	2021

[40]	IL13R⍺ 2-CAR T cells for Immunotherapy of Glioblastoma
	2021

[41]	The Application of Nanobody in CAR-T Therapy. Biomolecules 2021, 11, 238
	2021

[42]	Autoinduction as Means for Optimization of the Heterologous Expression of Recombinant Single-Chain Fv (scFv) Antibodies
	2021

[43]	Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation
	2021

[44]	Development of novel anti-mouse CD19 single-chain variable-fragments and establishment of an immunocompetent B-cell malignancy mouse model for the …
	2021

[45]	Autoimmune encephalitis: novel therapeutic targets at the preclinical level
	2021

[46]	The Application of Nanobody in CAR-T Therapy
	2021

[47]	The antigen‐binding moiety in the driver's seat of CARs
	2021

[48]	Protection of Alcohol Dehydrogenase against Freeze–Thaw Stress by Ice-Binding Proteins Is Proportional to Their Ice Recrystallization Inhibition Property
	2020

[49]	Live long and active: Polypeptide-mediated assembly of antibody variable fragments
	2020

[50]	CAR-T design: Elements and their synergistic function
	2020

[51]	Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments
	2020

[52]	Development of active tumor targeting systems for delivery of siRNA and drugs into breast and colorectal cancer
	2020

[53]	Public and private human T cell clones respond differentially to HCMV antigen when boosted by CD3 co-potentiation
	2020

[54]	Driving CARs with alternative navigation tools–the potential of engineered binding scaffolds
	2020

[55]	CAR-T-Zellen erkennen und eliminieren den Thyreotropin-Rezeptor exprimierende differenzierte Schilddrüsenkarzinomzellen
	2020

[56]	Calcium-dependent affinity ligands for protein purification
	2020

[57]	ШАПЕРОННАЯ И ИММУНОГЛОБУЛИНСВЯЗЫВАЮЩАЯ АКТИВНОСТИ Skp ИЗ Yersinia pseudotuberculosis
	2020

[58]	Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation
	2020

[59]	Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody FragmentsVHH-Secreting CAR T Cells
	Cancer immunology …, 2020

[60]	Advances in point-of-care testing for cardiovascular diseases
	2020

[61]	Development of recombinant antibody fragments for toxin and microbial contaminant detection and investigations of microcystin and azaspiracid toxicity.
	2019

[62]	Exploring and exploiting the minor pilins of Type IV pili
	2019

[63]	Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development
	2019

[64]	Chaperone and Immunoglobulin-Binding Activities of Skp Protein from Yersinia pseudotuberculosis
	Biochemistry (Moscow), 2019

[65]	Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex
	2019

[66]	Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage
	Materials Horizons, 2019

[67]	Amino acid induced hyper activation of laccase and its application in dye degradation
	2019

[68]	Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono-and Bi-specific Antitumor Activity of T Cells
	2019

[69]	Improving developability of an Antigen Binding Fragment by Aspartate Substitutions
	2019

[70]	An Antibody Fab Fragment-based Chimeric Antigen Receptor Could Efficiently Eliminate Human Thyroid Cancer Cells
	2019

[71]	Design and Production of Bispecific Antibodies
	2019

[72]	Developing VHH-based tools to study Ebolavirus infection
	2019

[73]	Pre-clinical development of novel ROR1 chimeric antigen receptor T cells and bispecific T cell engagers
	2018

[74]	Introduction into Novel Constructs
	Challenges in Protein Product Development, 2018

[75]	Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae
	Protein Expression and Purification, 2018

[76]	Strategies to Address Chimeric Antigen Receptor Tonic Signaling
	2018

[77]	Expression and neutralization capacity of single domain HIV antibody fragments
	2018

[78]	Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells
	mAbs, 2018

[79]	Bacterial communities adapted to higher external resistance can reduce the onset potential of anode in microbial fuel cells
	2018

[80]	Optimizing Antibody Expression: the nuts and Bolts
	Methods, 2017

[81]	Development of humanized scFv antibody fragment (s) that targets and blocks specific HLA alleles linked to myasthenia gravis
	Applied Microbiology and Biotechnology, 2017

[82]	Molecular Effects of Concentrated Solutes on Protein Hydration, Dynamics, and Electrostatics
	Biophysical Journal, 2016

[83]	Antibody Aggregation: Insights from Sequence and Structure
	Antibodies, 2016

[84]	Testing the anti-fibrotic potential of the single-chain Fv antibody against the α 2 C-terminal telopeptide of collagen I
	Connective tissue research, 2013

[85]	ECCENTRIC

[1]	Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell function Scientific Reports, 2025 DOI:10.1038/s41598-025-87944-2

[2]	Recent advances on CAR-T signaling pave the way for prolonged persistence and new modalities in clinic Frontiers in Immunology, 2024 DOI:10.3389/fimmu.2024.1335424

[3]	Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry mAbs, 2024 DOI:10.1080/19420862.2024.2334783

[4]	Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement Immunology, 2024 DOI:10.1111/imm.13752

[5]	Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances Journal of Controlled Release, 2024 DOI:10.1016/j.jconrel.2024.02.033

[6]	Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement Immunology, 2024 DOI:10.1111/imm.13752

[7]	Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances Journal of Controlled Release, 2024 DOI:10.1016/j.jconrel.2024.02.033

[8]	Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties International Journal of Molecular Sciences, 2024 DOI:10.3390/ijms25115634

[9]	Exosome-mimetic vesicles derived from fibroblasts carrying matrine for wound healing Burns & Trauma, 2024 DOI:10.1093/burnst/tkae015

[10]	Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors PNAS Nexus, 2024 DOI:10.1093/pnasnexus/pgae184

[11]	Immune Checkpoint Biology in Health and Disease International Review of Cell and Molecular Biology, 2024 DOI:10.1016/bs.ircmb.2023.03.003

[12]	Immunoglobulin constant regions provide stabilization to the paratope and enforce epitope specificity Journal of Biological Chemistry, 2024 DOI:10.1016/j.jbc.2024.107397

[13]	B7-H3–Targeting Chimeric Antigen Receptors Epstein-Barr Virus–specific T Cells Provides a Tumor Agnostic Off-The-Shelf Therapy Against B7-H3–positive Solid Tumors Cancer Research Communications, 2024 DOI:10.1158/2767-9764.CRC-23-0538

[14]	Higher Order Structure Characterization of Two Interdomain Disulfide Bond Variants of a Bispecific Monoclonal Antibody Journal of Pharmaceutical Sciences, 2024 DOI:10.1016/j.xphs.2024.05.007

[15]	NMDA receptor autoantibodies primarily impair the extrasynaptic compartment Brain, 2024 DOI:10.1093/brain/awae163

[16]	Selection and characterization of human scFvs targeting the SARS-CoV-2 nucleocapsid protein isolated from antibody libraries of COVID-19 patients Scientific Reports, 2024 DOI:10.1038/s41598-024-66558-0

[17]	Targeting CEA in metastatic triple negative breast cancer with image-guided radiation followed by Fab-mediated chimeric antigen receptor (CAR) T-cell therapy Frontiers in Immunology, 2024 DOI:10.3389/fimmu.2024.1499471

[18]	Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances Journal of Controlled Release, 2024 DOI:10.1016/j.jconrel.2024.02.033

[19]	Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry mAbs, 2024 DOI:10.1080/19420862.2024.2334783

[20]	“Stapling” scFv for multispecific biotherapeutics of superior properties mAbs, 2023 DOI:10.1080/19420862.2023.2195517

[21]	Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice International Journal of Molecular Sciences, 2023 DOI:10.3390/ijms241411643

[22]	“Stapling” scFv for multispecific biotherapeutics of superior properties mAbs, 2023 DOI:10.1080/19420862.2023.2195517

[23]	NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies Brain, 2023 DOI:10.1093/brain/awac497

[24]	International Review of Cell and Molecular Biology, 2023 DOI:10.1016/bs.ircmb.2023.03.003

[25]	Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models International Journal of Molecular Sciences, 2023 DOI:10.3390/ijms24087626

[26]	“Stapling” scFv for multispecific biotherapeutics of superior properties mAbs, 2023 DOI:10.1080/19420862.2023.2195517

[27]	NMDA-receptor-Fc-fusion constructs neutralize anti-NMDA receptor antibodies Brain, 2023 DOI:10.1093/brain/awac497

[28]	Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing Applied Sciences, 2023 DOI:10.3390/app132011520

[29]	New Antibody Formats International Review of Cell and Molecular Biology, 2022 DOI:10.1016/bs.ircmb.2022.03.010

[30]	Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis Molecular Pharmaceutics, 2022 DOI:10.1021/acs.molpharmaceut.1c00918

[31]	Nanobody-based CAR-T cells for cancer immunotherapy Biomarker Research, 2022 DOI:10.1186/s40364-022-00371-7

[32]	The antigen‐binding moiety in the driver's seat of CARs Medicinal Research Reviews, 2022 DOI:10.1002/med.21818

[33]	Biodistribution and Activity of EGFR Targeted Polymeric Micelles Delivering a New Inhibitor of DNA Repair to Orthotopic Colorectal Cancer Xenografts with Metastasis Molecular Pharmaceutics, 2022 DOI:10.1021/acs.molpharmaceut.1c00918

[34]	New Antibody Formats International Review of Cell and Molecular Biology, 2022 DOI:10.1016/bs.ircmb.2022.03.010

[35]	Improvement in the binding specificity of anti-isomiroestrol antibodies by expression as fragments under oxidizing conditions inside the SHuffle T7 E. coli cytoplasm Bioscience, Biotechnology, and Biochemistry, 2022 DOI:10.1093/bbb/zbac126

[36]	Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors Frontiers in Immunology, 2022 DOI:10.3389/fimmu.2022.1005800

[37]	Natural killer cells in clinical development as non-engineered, engineered, and combination therapies Journal of Hematology & Oncology, 2022 DOI:10.1186/s13045-022-01382-5

[38]	A 33-residue peptide tag increases solubility and stability of Escherichia coli produced single-chain antibody fragments Nature Communications, 2022 DOI:10.1038/s41467-022-32423-9

[39]	Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains Frontiers in Molecular Medicine, 2022 DOI:10.3389/fmmed.2022.1049580

[40]	Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains Frontiers in Molecular Medicine, 2022 DOI:10.3389/fmmed.2022.1049580

[41]	Advances in Clinical Chemistry, 2021 DOI:10.1016/bs.acc.2020.09.001

[42]	Advances in Clinical Chemistry, 2021 DOI:10.1016/bs.acc.2020.09.001

[43]	Autoinduction as Means for Optimization of the Heterologous Expression of Recombinant Single-Chain Fv (scFv) Antibodies Molecular Biotechnology, 2021 DOI:10.1007/s12033-021-00363-2

[44]	Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation Journal of Pharmaceutical Sciences, 2021 DOI:10.1016/j.xphs.2020.12.014

[45]	The Application of Nanobody in CAR-T Therapy Biomolecules, 2021 DOI:10.3390/biom11020238

[46]	CAR-NK Cells in the Treatment of Solid Tumors International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22115899

[47]	Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds The FEBS Journal, 2021 DOI:10.1111/febs.15523

[48]	Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing Cells, 2021 DOI:10.3390/cells11010021

[49]	The Application of Nanobody in CAR-T Therapy Biomolecules, 2021 DOI:10.3390/biom11020238

[50]	CAR-NK Cells in the Treatment of Solid Tumors International Journal of Molecular Sciences, 2021 DOI:10.3390/ijms22115899

[51]	Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing Cells, 2021 DOI:10.3390/cells11010021

[52]	Protection of Alcohol Dehydrogenase against Freeze–Thaw Stress by Ice-Binding Proteins Is Proportional to Their Ice Recrystallization Inhibition Property Marine Drugs, 2020 DOI:10.3390/md18120638

[53]	Chaperone and Immunoglobulin-Binding Activities of Skp Protein from Yersinia pseudotuberculosis Biochemistry (Moscow), 2020 DOI:10.1134/S0006297920010071

[54]	CAR-T design: Elements and their synergistic function EBioMedicine, 2020 DOI:10.1016/j.ebiom.2020.102931

[55]	Driving CARs with alternative navigation tools – the potential of engineered binding scaffolds The FEBS Journal, 2020 DOI:10.1111/febs.15523

[56]	Live long and active: Polypeptide-mediated assembly of antibody variable fragments Advanced Drug Delivery Reviews, 2020 DOI:10.1016/j.addr.2020.10.017

[57]	Public and private human T-cell clones respond differentially to HCMV antigen when boosted by CD3 copotentiation Blood Advances, 2020 DOI:10.1182/bloodadvances.2020002255

[58]	Autoimmune encephalitis: novel therapeutic targets at the preclinical level Expert Opinion on Therapeutic Targets, 2020 DOI:10.1080/14728222.2021.1856370

[59]	Protection of Alcohol Dehydrogenase against Freeze–Thaw Stress by Ice-Binding Proteins Is Proportional to Their Ice Recrystallization Inhibition Property Marine Drugs, 2020 DOI:10.3390/md18120638

[60]	Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments Cancer Immunology Research, 2020 DOI:10.1158/2326-6066.CIR-19-0734

[61]	Biochemical and Structural Insights into Carbonic Anhydrase XII/Fab6A10 Complex Journal of Molecular Biology, 2019 DOI:10.1016/j.jmb.2019.10.022

[62]	Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions Biochemistry, 2019 DOI:10.1021/acs.biochem.9b00251

[63]	Ice-recrystallization inhibiting polymers protect proteins against freeze-stress and enable glycerol-free cryostorage Materials Horizons, 2019 DOI:10.1039/C8MH00727F

[64]	Amino acid induced hyper activation of laccase and its application in dye degradation Biocatalysis and Agricultural Biotechnology, 2019 DOI:10.1016/j.bcab.2019.101064

[65]	Chimeric Antigen Receptors Incorporating D Domains Targeting CD123 Direct Potent Mono- and Bi-specific Antitumor Activity of T Cells Molecular Therapy, 2019 DOI:10.1016/j.ymthe.2019.04.010

[66]	Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development mAbs, 2019 DOI:10.1080/19420862.2019.1660564

[67]	Design and Production of Bispecific Antibodies Antibodies, 2019 DOI:10.3390/antib8030043

[68]	Design and Production of Bispecific Antibodies Antibodies, 2019 DOI:10.3390/antib8030043

[69]	Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions Biochemistry, 2019 DOI:10.1021/acs.biochem.9b00251

[70]	Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae Protein Expression and Purification, 2018 DOI:10.1016/j.pep.2018.05.009

[71]	Challenges in Protein Product Development AAPS Advances in the Pharmaceutical Sciences Series, 2018 DOI:10.1007/978-3-319-90603-4_22

[72]	Design, selection and optimization of an anti-TRAIL-R2/anti-CD3 bispecific antibody able to educate T cells to recognize and destroy cancer cells mAbs, 2018 DOI:10.1080/19420862.2018.1494105

[73]	Strategies to Address Chimeric Antigen Receptor Tonic Signaling Molecular Cancer Therapeutics, 2018 DOI:10.1158/1535-7163.MCT-17-1097

[74]	Optimizing antibody expression: The nuts and bolts Methods, 2017 DOI:10.1016/j.ymeth.2017.01.009

[75]	Development of humanized scFv antibody fragment(s) that targets and blocks specific HLA alleles linked to myasthenia gravis Applied Microbiology and Biotechnology, 2017 DOI:10.1007/s00253-017-8557-1

[76]	Antibody Aggregation: Insights from Sequence and Structure Antibodies, 2016 DOI:10.3390/antib5030019

[77]	Molecular Effects of Concentrated Solutes on Protein Hydration, Dynamics, and Electrostatics Biophysical Journal, 2016 DOI:10.1016/j.bpj.2016.07.011

[78]	Antibody Aggregation: Insights from Sequence and Structure Antibodies, 2016 DOI:10.3390/antib5030019

[79]	Testing the anti-fibrotic potential of the single-chain Fv antibody against theα2 C-terminal telopeptide of collagen I Connective Tissue Research, 2014 DOI:10.3109/03008207.2013.862528

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Advances in Bioscience and Biotechnology

Advances in Bioscience and Biotechnology

Journals Menu

Home

About SCIRP

Service

Policies